Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Therapeutic Strategies for Microvascular Dysfunction in Type 1 Diabetes

NCT05478707 is registered in ClinicalTrials.gov with AdventHealth Translational Research Institute as lead sponsor.

NCT NCT05478707
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05478707 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Therapeutic Strategies for Microvascular Dysfunction in Type 1 Diabetes
Lead sponsor
AdventHealth Translational Research Institute
Phase
Phase 2
Overall status
Recruiting
Start date
October 5, 2023
Completion date
July 30, 2028
Enrollment
47 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes mellitus, type 1, endothelial dysfunction